CLN-049

Asset

T cell engager targeting FLT3

Stage
Phase 2
Modality
Antibody
Target
FLT3
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets